论文信息 - A first-in-human, phase I study of an oral hedgehog (HH) pathway antagonist, BMS-833923 (XL139), in subjects with advanced or metastatic solid tumors. - 字舞流文

A first-in-human, phase I study of an oral hedgehog (HH) pathway antagonist, BMS-833923 (XL139), in subjects with advanced or metastatic solid tumors.

Lixin Lang | S. Alberts | K. Papadopoulos | L. Siu | B. Vakkalagadda | C. Ahlers | K. Bennett | J. V. Tornout | R. Kirchoff-Ross | J. Tornout